An innovative medical device addressing the unmet need for IBD patients. Dedicated for Vacuum Assisted Closure of fistula tracts and abscesses. With a special focus on patients suffering from perianal fistulas, the most common complication in Crohn's Disease. Suitable for outpatient settings.
The Semiflex Dome System aims to meet the unmet need of the IBD Community and become the leading device for the treatment of fistulas. This vacuum therapy is amenable for the majority of patients with perianal disease, irrespective of the number of internal openings and tracts. The transition from acute treatment to ambulatory care that it will enable, will be a major breakthrough in the management and treatment of fistulas.
The primary beneficiary of this product is IBD patient group. Non-IBD patient group is the secondary beneficiary, e. g. cryptoglandular or enterocutaneous fistula.
Participant of IBD Innovate Conference 2019 in New York https://site.crohnscolitisfoundation.org/ibdinnovate.html
Contact: contact@semiflexsystem.com
Company Details
Semiflex Questions
Semiflex's LinkedIn profile is https://pl.linkedin.com/company/semiflex-dome-system
Semiflex has
11 employees.
View email and phone details for 11
employees at Semiflex.
Semiflex's industry is
Medical Device
Semiflex's top competitors are
Fundacja Panheri,
Hugup,
Biomedical Valley,
Kidos,
Panheri,
Maverx Foundation,
Genesys Bio,
Z Nami Zarządzanie Najmem Mieszkań,
3d Bistro,
Iconic Feet Shoe Trading Llc.
Semiflex's categories are Medical Device
Semiflex's founding year is 2019
